van der Fits, Leslie <br/><br/>
In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.  [electronic resource] 

 -  The Journal of investigative dermatology  Jan 2004 
 - 51-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-202X 
<br/><br/><label>Standard No.: </label>10.1046/j.0022-202X.2003.22113.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents--metabolism<br/>Biopsy<br/>Cell Nucleus--metabolism<br/>Cells, Cultured<br/>DNA-Binding Proteins--genetics<br/>Female<br/>Gene Expression--immunology<br/>Humans<br/>Interferon Regulatory Factor-7<br/>Interferon-Stimulated Gene Factor 3<br/>Interferon-Stimulated Gene Factor 3, gamma Subunit<br/>Interferon-alpha--metabolism<br/>Interferon-beta--metabolism<br/>Keratinocytes--cytology<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Psoriasis--metabolism<br/>RNA, Messenger--analysis<br/>STAT1 Transcription Factor<br/>Signal Transduction--drug effects<br/>Trans-Activators--metabolism<br/>Transcription Factors--metabolism